Filing Details
- Accession Number:
- 0001209191-21-016136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-02 16:51:17
- Reporting Period:
- 2021-02-26
- Accepted Time:
- 2021-03-02 16:51:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1524472 | Xylem Inc. | XYL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383582 | Kairus Tarapore | 1 International Drive C/O Xylem Inc. Rye Brook NY 10573 | Svp & Chro | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-26 | 2,777 | $99.95 | 13,506 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-27 | 249 | $102.23 | 13,257 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 1,553 | $0.00 | 14,810 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common | Stock Option (Right to Buy) | Acquisiton | 2021-03-01 | 6,843 | $0.00 | 6,843 | $102.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,843 | 2031-03-01 | No | 4 | A | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on November 6, 2020.
- This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,777 shares that were executed at price of $99.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on Feb 27, 2020 under the Xylem 2011 Omnibus Incentive Plan
- Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024
- Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2022, March 1, 2023 and March 1, 2024.
Billionaire Hedge Funds
